Daniel Deck

Statistics

Publications

Citations

127

H-Index

Active since

2012

Affiliations

Paratek Pharmaceuticals (United States)(Current)

San Francisco General Hospital

Johns Hopkins Medicine

University of California, San Francisco

Johns Hopkins University

Daniel Deck is an author at Paratek Pharmaceuticals (United States) specializing in infectious diseases, antimicrobial pharmacotherapy, and antibiotic resistance.

Publications per year

2012–2024

Publications

Does Doxycycline Protect Against Development of Clostridium difficile Infection?

Sarah B. Doernberg, Lisa G. Winston, Daniel Deck et al. · Clinical Infectious Diseases · 2012 · 60 citations · Full text

Medicine, Infectious Diseases, Pharmacology +10

Efficacy of Omadacycline-Containing Regimen in a Mouse Model of Pulmonary Mycobacteroides abscessus Disease

Binayak Rimal, Danielle A. Nicklas, Chandra M. Panthi et al. · mSphere · 2023 · 20 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +11

Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia

Sanjiv M. Baxi, Angelo Clemenzi-Allen, Alice Gahbauer et al. · Antimicrobial Agents and Chemotherapy · 2016 · 19 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting

Daniel Deck, Jennifer M. Jordan, Thomas L Holland et al. · Infectious Diseases and Therapy · 2016 · 17 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Efficacies of three drug regimens containing omadacycline to treat Mycobacteroides abscessus disease

Binayak Rimal, Chandra M. Panthi, Yi Xie et al. · Tuberculosis · 2024 · 11 citations · Full text

Medicine, Infectious Diseases, Pharmacology +15

1–5 of 5